Center for Regenerative Therapies Dresden

What Center for Regenerative Therapies Dresden does

The Center for Regenerative Therapies Dresden (CRTD) is a university research center within the Center for Molecular and Cellular Bioengineering (CMCB) at TUD Dresden University of Technology, located at Fetscherstraße 105, 01307 Dresden, Germany. CRTD conducts basic and translational research in regenerative medicine, with the stated mission of discovering principles of cell and tissue regeneration and leveraging these for the recognition, treatment, and reversal of diseases. Its research groups work across a diverse set of model organisms, organ systems (central nervous system, retina, hematopoietic system, pancreas, bone), and disease models, and apply a broad methodological spectrum spanning basic research through validation projects and clinical studies. The center links bench science to clinical application, bringing expertise in stem cells, gene-editing, and tissue regeneration toward innovative therapies for metabolic, osteo-hematological, and neurological diseases, supported by a technology platform that provides core facility access to state-of-the-art research equipment.

CRTD does not sell commercial products or services and does not generate commercial revenue. Its operating model is entirely grant-funded: research is supported by institutional funding from TU Dresden, the DFG (German Research Foundation, via its DFG Research Center designation for Regenerative Therapies Dresden), the BMBF (German Federal Ministry of Education and Research), the Free State of Saxony, the European Union/EFRE structural funds, and ZIK (Unternehmen Region) project grants. The center operates within the Dresden-concept alliance alongside partner institutions BIOTEC and BCUBE, sharing infrastructure and research collaboration on the CMCB campus. Its primary stakeholder audience is the academic and clinical research community, including scientists, clinicians, students, and ultimately patients benefiting from regenerative therapies. Research findings are disseminated through peer-reviewed publications and academic conferences rather than commercial channels. As of the input, CRTD has 11-50 employees and is led by Director Prof. Mike O. Karl, appointed July 14, 2026.

Name

Center for Regenerative Therapies Dresden

Legal name

Center for Regenerative Therapies Dresden (CRTD)

Website

https://crt-dresden.de

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

The Center for Regenerative Therapies Dresden (CRTD) is a publicly funded university research center within TU Dresden that conducts basic and translational research in regenerative medicine across multiple organ systems and disease models, serving the academic and clinical research community.

Ownership category

akta.pro rank

Product category

Academic Biomedical Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Stem Cell–Based Regenerative Therapies (HLAAAGAA)

akta.pro secondary industries

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Neural & Spinal Cord Regeneration (HLAAAGAI)

Keywords

• Regenerative medicine research
• Stem cell research
• Tissue regeneration studies
• Translational biomedical research
• Gene editing research

Headquarters

HQ city

Dresden, Saxony

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Core offering

The Center for Regenerative Therapies Dresden (CRTD) is a university research center that conducts basic and translational research in regenerative medicine. It studies the principles of cell and tissue regeneration across diverse model organisms, organ systems, and disease models — including the central nervous system, retina, hematopoietic system, pancreas, and bone — and leverages these findings toward recognition, treatment, and reversal of metabolic, osteo-hematological, and neurological diseases using stem cells, gene-editing, and regenerative approaches.

Product overview

The Center for Regenerative Therapies Dresden (CRTD) is a research center within TU Dresden's Center for Molecular and Cellular Bioengineering (CMCB). It is not a product or technology company; rather, it conducts basic and translational research focused on discovering principles of cell and tissue regeneration for the treatment and reversal of diseases. CRTD offers no commercial products or services. Its activities encompass research groups studying regeneration mechanisms, a technology platform providing core facility access, and educational programs linking bench research to clinical applications in metabolic, osteo-hematological, and neurological diseases using stem cells, gene-editing, and regenerative approaches.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core.

• DFG (German Research Foundation) / DFG-Forschungszentrum Regenerative Therapien DresdencoreStrategic or Co-development PartnerCRTD is the DFG Research Center for Regenerative Therapies Dresden, funded through the German Research Foundation's excellence initiative.
• BIOTEC (Biotechnology Center of TU Dresden)coreStrategic or Co-development PartnerCRTD works closely with BIOTEC, sharing the CMCB campus. BIOTEC is a key partner institution within the Dresden-concept research network.
• BCUBE (Center for Molecular Bioimaging)coreStrategic or Co-development PartnerBCUBE is listed as a partner institution, sharing infrastructure and research collaboration within the CMCB ecosystem of TU Dresden.
• Dresden-conceptcoreStrategic or Co-development PartnerCRTD is part of the Dresden-concept alliance, a research partnership of Dresden's leading research institutions.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Direct peers

• Harvard Stem Cell Institute: Harvard Stem Cell Institute is an interdisciplinary research and translation consortium focused on stem-cell biology and regenerative medicine. It overlaps with CRTD's multidisciplinary regenerative research and its emphasis on moving discoveries toward clinical application.
• Centre for Regenerative Medicine, University of Edinburgh: The University of Edinburgh Centre for Regenerative Medicine studies stem cells and regenerative processes across diseases, with an academic-to-clinical translation model comparable to CRTD. It is a relevant peer in regenerative mechanisms and therapeutic development.
• USC Stem Cell: USC Stem Cell is a university-wide initiative combining stem-cell biology, regenerative medicine, and translational research. Its disease-focused programs and shared research infrastructure make it directly comparable to CRTD.
• Center for Regenerative Medicine (CReM), Boston University: CReM at Boston University conducts stem-cell and regenerative-medicine research with an emphasis on translating findings into therapies. Its academic, multi-program, translational orientation is similar to CRTD's research-center model.
• Berlin-Brandenburg Center for Regenerative Therapies (BCRT): BCRT is an academic translational research center focused on regenerative medicine and cell-based therapies, making it a close analogue to CRTD's bench-to-clinic regenerative research. It serves comparable academic, clinical, and industry research collaborators, although it operates in the Berlin-Brandenburg ecosystem.
• Institute for Stem Cell and Regenerative Medicine (ISCRM), University of Washington: ISCRM brings stem-cell and regenerative-medicine researchers together across basic and translational programs, matching CRTD's focus on stem cells, tissue regeneration, and disease modeling. It is a direct academic research peer with a comparable interdisciplinary operating model.
• Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW): reNEW develops stem-cell-based disease models and therapeutic research across its international university network. Its focus on stem-cell medicine and translational application directly overlaps with CRTD's stem-cell and regenerative-therapy work.
• Stanford Institute for Stem Cell Biology and Regenerative Medicine: Stanford's institute combines basic stem-cell biology with regenerative medicine and disease research. It overlaps with CRTD's methods, disease models, and stated bench-to-clinic orientation.

Emerging players

• German Center for Neurodegenerative Diseases (DZNE): DZNE is a German public research organization focused on neurodegenerative diseases and related mechanisms. It is a relevant emerging peer for CRTD's neurological and retinal disease research, although its core mission is broader neurodegeneration rather than regenerative therapy.
• Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG): MPI-CBG conducts molecular cell-biology and bioengineering research in Dresden and participates in the same wider research ecosystem. Its cell-biology focus and shared location make it a strong regional scientific peer, although it is broader than regenerative medicine.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/center-for-regenerative-therapies-dresden
• Instagraminstagram.com/cmcb_tud

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Center for Regenerative Therapies Dresden